Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 589-600 of 2,301
Drug study icon
CompletedNCT05439603

ANC-501 in the Treatment of Adults With Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.
Condition
Depression
Drug study icon
CompletedNCT04285515

study Evaluating Lumateperone Monotherapy in the Treatment of Depression in bipolarity or Major Depressive Disorder

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Russia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Depression, Bipolarity
Device study icon
CompletedNCT01898429

Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD)

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

Remote / online
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 70 Years
Countries
United States
Sponsor
Paul Holtzheimer
Condition
Depression, Bipolarity
Device study icon
CompletedNCT04448327

Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression

This study is looking at care and outcomes for people with depression. Some participants may receive Sham tVNS instead of the study treatment, and direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 50 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Device study icon
Active Not RecruitingNCT06874374

Individualized Non-invasive Brain Stimulation for Major Depressive Disorder

This observational study is following people with Depression - depression or Transcranial Alternating Current Stimulation to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 70 Years
Countries
United States
Sponsor
Pulvinar Neuro, LLC
Condition
Depression
Drug study icon
CompletedNCT02461927

Ketamine for the Rapid Treatment of Major Depressive Disorder and Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Depression, Addiction
Drug study icon
CompletedNCT01582945

Ketamine Infusion for Treatment-resistant Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Drug study icon
CompletedNCT05061706

Lumateperone for depression

This study is completed in the United States, in Argentina, in Bulgaria, .... It is testing lumateperone for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Argentina, Bulgaria, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.